MedPath

A exploratory study of the efficacy and safety of oxaliplatin in combination with S-1 in the treatment of non-resectable gastric cancer

Not Applicable
Recruiting
Conditions
non-resectable gastric cancer or reccurent gastric cancer
Registration Number
JPRN-UMIN000002463
Lead Sponsor
niversity of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

history of use of oxaliplatin severe dysfuntion of major organs Hematopoietic disorder sensory neuropathy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
response rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath